BASELINE RENAL FUNCTION AS A PROGNOSTIC INDICATOR IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH R-CHOP IMMUNOCHEMOTHERAPY

被引：0
|
作者：
Hong, J. [1 ]
Lee, S. [1 ]
Park, J. [1 ]
Ahn, J. Y. [2 ]
Jung, J. Y. [1 ]
Lee, J. H. [1 ]
机构：
[1] Gachon Univ, Coll Med, Dept Internal Med, Inchon, South Korea
[2] Gachon Univ, Coll Med, Dept Lab Med, Inchon, South Korea
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1694
引用
收藏
页码：690 / 690
页数：1
相关论文
共 50 条
  • [21] Prognostic Impact Of Gender In Diffuse Large B Cell Lymphoma Patients Treated With R-CHOP Therapy
    Takahashi, Hiroyuki
    Tomita, Naoto
    Kawasaki, Rika
    Hashimoto, Chizuko
    Yamazaki, Etsuko
    Taguchi, Jun
    Sakai, Rika
    Fujisawa, Shin
    Ogawa, Koji
    Ishigatsubo, Yoshiaki
    BLOOD, 2013, 122 (21)
  • [22] Pharmacodynamics of Rivaroxaban and Dabigatran in Adults with Diffuse Large B-Cell Lymphoma Receiving R-CHOP Immunochemotherapy
    Punnachet, Teerachat
    Cressey, Tim R.
    Apiwatnakorn, Porntipa
    Koonarat, Atisa
    Norasetthada, Lalita
    Tantiworawit, Adisak
    Rattarittamrong, Ekarat
    Rattanathammethee, Thanawat
    Hantrakool, Sasinee
    Piriyakhuntorn, Pokpong
    Hantrakun, Nonthakorn
    Niprapan, Piangrawee
    Chai-Adisaksopha, Chatree
    PHARMACEUTICS, 2024, 16 (10)
  • [23] Screening of key genes associated with R-CHOP immunochemotherapy and construction of a prognostic risk model in diffuse large B-cell lymphoma
    Liu, Ran
    Chen, Zhi
    Wang, Shujun
    Zhao, Gang
    Gu, Yan
    Han, Qi
    Chen, Baoan
    MOLECULAR MEDICINE REPORTS, 2019, 20 (04) : 3679 - 3690
  • [24] Body Composition as a Predictor of Toxicity and Prognosis in Patients with Diffuse Large B-Cell Lymphoma Receiving R-CHOP Immunochemotherapy
    Guo, Jiaxun
    Cai, Panpan
    Li, Pengfei
    Cao, Cong
    Zhou, Jing
    Dong, Lina
    Yang, Yan
    Xuan, Qijia
    Wang, Jingxuan
    Zhang, Qingyuan
    CURRENT ONCOLOGY, 2021, 28 (02) : 1325 - 1337
  • [25] Pneumocystis jirovecii pneumonia in diffuse large B-cell Lymphoma treated with R-CHOP
    Lee, Ji Yun
    Kang, Minsu
    Suh, Koung Jin
    Kim, Ji-Won
    Kim, Se Hyun
    Kim, Jin Won
    Kim, Yu Jung
    Song, Kyoung-Ho
    Kim, Eu Suk
    Kim, Hong Bin
    Lee, Keun-Wook
    Kim, Jee Hyun
    Bang, Soo-Mee
    Lee, Jong-Seok
    Lee, Jeong-Ok
    MYCOSES, 2021, 64 (01) : 60 - 65
  • [26] Prognostic Value of Occult Bone Marrow Involvement Estimated by Immunoglobulin Clonality Assay in Patients with Diffuse Large B-cell Lymphoma Treated with R-CHOP Immunochemotherapy
    Seo, J.
    Hong, J.
    Kim, M.
    Jeong, J.
    Kim, K.
    Ahn, J.
    Park, J.
    Lee, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06) : 768 - 768
  • [27] Prognostic value of Waldeyer's ring involvement of diffuse large B-cell lymphoma treated with R-CHOP
    Oh, Min-Young
    Chung, Joo-Seop
    Song, Moo-Kon
    Shin, Ho-Jin
    Lee, Ho-Sup
    Lee, Sang-Min
    Lee, Gyeong-Won
    Lee, Su-Ee
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (03) : 397 - 402
  • [28] Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy
    Gomez-Gelvez, Juan C.
    Salama, Mohamed E.
    Perkins, Sherrie L.
    Leavitt, Matthew
    Inamdar, Kedar V.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 145 (04) : 514 - 523
  • [29] Prognostic value of Waldeyer’s ring involvement of diffuse large B-cell lymphoma treated with R-CHOP
    Min-Young Oh
    Joo-Seop Chung
    Moo-Kon Song
    Ho-Jin Shin
    Ho-Sup Lee
    Sang-Min Lee
    Gyeong-Won Lee
    Su-Ee Lee
    International Journal of Hematology, 2013, 97 : 397 - 402
  • [30] Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOP
    Castillo, Jorge J.
    Sinclair, Natalie
    Beltran, Brady E.
    Song, Moo-Kon
    Ilic, Ivana
    Leppa, Sirpa
    Nurmi, Heidi
    Seki, Ritsuko
    Uccella, Silvia
    Li, Jun-Min
    Treaba, Diana O.
    Stachurski, Dariusz
    Butera, James N.
    LEUKEMIA RESEARCH, 2013, 37 (04) : 386 - 391
12345